Fact-checked by Grok 2 weeks ago

Histopathology

Histopathology is the microscopic study of diseased cells and tissues, involving the preparation, staining, and examination of tissue samples to identify pathological changes and diagnose diseases.^[1] It represents a branch of pathology focused on the structural and functional alterations in tissues caused by illness, serving as the gold standard for confirming diagnoses in conditions such as cancer.^[2]^[3] The process of histopathology begins with tissue collection via biopsy or autopsy, followed by fixation—typically in neutral buffered formalin—to preserve cellular architecture and prevent autolysis.^[3] Samples are then dehydrated, embedded in paraffin wax, and sectioned into thin slices (usually 4-5 micrometers thick) using a microtome for mounting on slides.^[3] Staining is applied next, with hematoxylin and eosin (H&E) being the most common routine method: hematoxylin stains nuclei blue to highlight DNA, while eosin stains cytoplasm and extracellular matrix pink, enabling visualization of cellular details and tissue organization under light microscopy.^[3] Specialized stains, such as periodic acid-Schiff (PAS) for carbohydrates or Masson's trichrome for collagen, may be used to detect specific features like fungi, amyloid, or fibrosis.^[3] In clinical practice, histopathologists interpret these slides to assess criteria like cell morphology, mitotic activity, necrosis, and invasion, which inform tumor grading, staging, and margins in oncology cases.^[2] This analysis is essential for prognosis, treatment planning—including decisions on surgery, chemotherapy, or radiation—and forensic investigations, where it helps determine causes of death.^[3]^[2] Variability in interpretation can occur, with studies showing major diagnostic changes in approximately 1% of cases upon second review, underscoring the need for clinical correlation and multidisciplinary input.^[4] The foundations of histopathology trace back to the 17th century with the development of microscopes by scientists like Antonie van Leeuwenhoek, enabling the first observations of cellular structures.^[5] By the late 18th century, Marie François Xavier Bichat established histology as a discipline by systematically classifying tissues, laying the groundwork for pathological applications in the 19th century through the work of Rudolf Virchow, who emphasized cellular pathology.^[5] Today, digital pathology, immunohistochemistry, and artificial intelligence have enhanced precision, integrating molecular markers for more targeted diagnostics (as of 2025).^[3]^[6]

Definition and Scope

Definition

Histopathology is the microscopic examination of tissue sections to study the manifestations of disease, focusing on the observation of normal and abnormal cellular architecture. Tissue specimens, obtained from biopsies or surgical resections, are processed into thin slices typically 4-5 micrometers thick, mounted on glass slides, and stained with dyes such as hematoxylin and eosin to enhance contrast and visibility of cellular details. These stained slides are then viewed under light microscopy to identify pathological changes at the cellular and tissue levels.^[7]^[8]^[3] At its core, histopathology relies on the integration of microscopic observations with gross pathology findings—such as the visible appearance of organs or tissues—and clinical patient data, including symptoms, imaging results, and laboratory tests. This correlative approach enables pathologists to diagnose diseases by linking structural alterations in tissues to underlying etiologies, commonly applied to conditions like cancer (e.g., identifying malignant cell proliferation), infections (e.g., detecting microbial invasion or inflammatory infiltrates), and inflammatory disorders (e.g., assessing patterns of immune cell accumulation). Such synthesis is essential for accurate disease classification and guides therapeutic decisions in multidisciplinary clinical settings.^[7]^[8]^[2] Unlike cytology, which involves the analysis of individual cells suspended in fluids, smears, or fine-needle aspirates to detect abnormalities in cellular morphology, histopathology emphasizes the examination of intact, fixed, and sectioned tissue structures for routine diagnostic evaluation. It also differs from autopsy pathology, a subspecialty focused on post-mortem analysis of whole organs or the entire body to determine causes of death, whereas histopathology primarily addresses tissues from living patients. In the broader context of pathology, histopathology provides critical diagnostic insights that inform clinical management.^[7]^[9]

Historical Development

The foundations of histopathology were laid in the 17th century with advancements in microscopy that enabled the visualization of tissues at a cellular level. Antonie van Leeuwenhoek, a Dutch scientist, significantly advanced the microscope in the 1670s by crafting single-lens instruments that allowed for the first detailed observations of microscopic structures, including cells and microorganisms, marking a pivotal step toward tissue analysis.^[10] Concurrently, Marcello Malpighi, an Italian physician, pioneered tissue sectioning techniques in the 1660s, using early microscopes to examine thin slices of organs such as frog lungs, thereby establishing the basis for histological study through prepared specimens.^[11] The 19th century brought transformative innovations that made histopathology a practical discipline for disease investigation. Rudolf Virchow, a German pathologist, introduced the theory of cellular pathology in 1858 through a series of lectures, positing that diseases arise from abnormalities in cells rather than humors, thus linking microscopy directly to pathological processes and founding modern histopathology.^[12] Building on this, Edwin Klebs developed paraffin embedding in 1869, a method that preserved tissues in wax for serial sectioning, facilitating more reliable microscopic examinations.^[13] In the 1880s, Paul Ehrlich advanced staining techniques using coal tar dyes, which differentiated cellular components like granulocytes in blood and tissues, enabling routine identification of pathological changes.^[14] The 20th century solidified histopathology's role in clinical practice through procedural and institutional developments. Louis B. Wilson introduced frozen section techniques in the early 1900s at the Mayo Clinic, allowing rapid intraoperative tissue diagnosis by freezing and sectioning specimens without embedding, which revolutionized surgical decision-making.^[15] Following World War II, histopathology emerged as a distinct medical specialty, driven by expanded laboratory infrastructure and increased demand for precise tissue-based diagnostics in hospitals worldwide.^[16]

Role in Medicine

Diagnostic Applications

Histopathology serves as the gold standard for confirming clinical diagnoses by examining microscopic tissue patterns, particularly in distinguishing malignancies such as carcinomas, which originate from epithelial cells and exhibit glandular or squamous differentiation, from sarcomas, which arise from mesenchymal tissues and display spindle cell or pleomorphic features.^[17]^[2] In infectious diseases, it identifies characteristic structures like caseating granulomas in tuberculosis, consisting of epithelioid macrophages, Langhans giant cells, and central necrosis, enabling definitive diagnosis when microbiological tests are inconclusive.^[18] For autoimmune conditions, histopathology reveals interface hepatitis with lymphoplasmacytic infiltrates and rosette formation in autoimmune hepatitis, supporting diagnosis alongside serological markers.^[19] In clinical workflows, histopathology integrates with imaging modalities such as ultrasound or CT to guide biopsies, achieving 90-95% accuracy in targeting suspicious lesions while minimizing invasiveness, followed by rapid reporting that directly informs treatment choices like neoadjuvant chemotherapy or surgical resection.^[20] This process ensures histopathological findings correlate with radiographic features, reducing diagnostic delays and enabling personalized oncology care. Limitations include sampling errors, where underestimation of malignancy occurs in up to 20-30% of breast core needle biopsies due to heterogeneous tumor sampling, necessitating repeat procedures in ambiguous cases.^[21] Accuracy in cancer diagnosis varies by site but is generally high; for breast cancer via core needle biopsy, histopathology yields a sensitivity of 94.2% and specificity of 88.1%, with positive predictive value of 84.8% and negative predictive value of 95.6%.^[22] Globally, histopathology underpins the World Health Organization (WHO) tumor classifications, providing morphological criteria for standardized tumor typing and grading that facilitate international consistency in diagnosis and therapy selection.^[23] It is also mandatory in surgical pathology reports per College of American Pathologists (CAP) guidelines, requiring inclusion of pathologic diagnosis, gross and microscopic descriptions, and tumor extent to ensure complete documentation for patient management.^[24]

Research and Prognostic Uses

Histopathology plays a crucial role in prognostic assessment by enabling the evaluation of tumor characteristics that predict disease progression and patient outcomes. One seminal example is the Gleason grading system for prostate cancer, developed by Donald Gleason in the 1960s and refined in 1974, which assigns scores from 6 to 10 based on the architectural patterns of glandular structures in biopsy or resection specimens, with higher scores indicating more aggressive disease and influencing treatment decisions such as active surveillance versus radical therapy.^[25]^[26] This system has been widely adopted due to its correlation with metastasis risk and survival rates, providing pathologists with a standardized method to guide clinical management.^[27] In research, histopathology facilitates the investigation of disease mechanisms by offering detailed morphological insights into pathological processes. For instance, in Alzheimer's disease studies, histopathological examination using special stains like Congo red or immunohistochemistry reveals amyloid plaques—extracellular aggregates of β-amyloid peptides that are a defining feature of the disease and contribute to neuronal damage—allowing researchers to correlate plaque distribution and density with cognitive decline.^[28]^[29] Additionally, histopathology is integral to preclinical drug development, where analysis of tissues from animal models provides morphologic context to biochemical and molecular data, assessing drug efficacy, toxicity, and off-target effects in contexts like inflammation or oncology.^[30] Emerging applications of histopathology extend to tissue biobanking for genomic research and personalized medicine, where preserved specimens undergo histopathological validation to confirm molecular alterations identified through sequencing or proteomics. In digital biobanks, histopathological data integrates with genomic and imaging profiles to enable precise subtype classification of diseases like cancer, supporting tailored therapies based on individual tumor histology and genetics.^[31]^[32] This approach has accelerated discoveries in precision oncology by linking histological patterns to actionable mutations. A notable example of histopathology's research impact is its role in elucidating COVID-19 pathology; autopsy studies from 2020 consistently identified diffuse alveolar damage as the predominant lung finding, characterized by hyaline membranes, alveolar edema, and type II pneumocyte hyperplasia, which informed understanding of the virus's acute respiratory effects and guided therapeutic strategies.^[33]

Specimen Collection

Types of Specimens

In histopathology, specimens are broadly categorized based on their origin and clinical context, primarily including biopsies, surgical resections, autopsy tissues, and select cytology-derived samples processed for histological analysis.^[34]^[35] These categories reflect the diverse sources from which tissue is obtained for microscopic examination to aid in diagnosis, staging, and research. Biopsies represent small tissue samples acquired to investigate suspected abnormalities, with common subtypes including needle core biopsies, endoscopic biopsies, and excisional biopsies. Needle core biopsies, often used for accessible lesions such as breast lumps, involve a larger needle to extract cylindrical tissue cores for detailed architectural assessment.^[35] Endoscopic biopsies, typically obtained during procedures like colonoscopy, target mucosal abnormalities such as colon polyps to evaluate for dysplasia or malignancy.^[35] Excisional biopsies entail the complete removal of a lesion, providing comprehensive sampling for both diagnostic and therapeutic purposes.^[35] Surgical specimens encompass larger tissue samples removed during operative procedures, such as resection pieces and lymph nodes for cancer staging. Resection specimens, like those from mastectomy, include entire organs or significant portions to assess margins, tumor extent, and multifocality.^[36] Lymph nodes, sampled during procedures like sentinel node biopsy, are critical for determining metastatic spread in cancers such as breast or melanoma.^[36] Autopsy tissues, derived from post-mortem examinations, provide samples for investigating causes of death, disease progression, or unexpected findings, often including organs like the heart, lungs, or brain.^[37] These specimens contribute to histopathological confirmation of clinical suspicions and epidemiological insights. Other sources include fine-needle aspirates processed as cell blocks for histological evaluation, particularly when cytological material is centrifuged and embedded to yield tissue-like sections for immunohistochemical or molecular studies.^[38] Specimens are distinguished by whether they originate from tumor or non-tumor tissues, influencing diagnostic focus; for instance, skin punch biopsies, which remove full-thickness cylindrical samples via a specialized tool, are commonly used in dermatopathology to assess inflammatory or neoplastic skin conditions.^[34] Proper handling protocols, as outlined in dedicated guidelines, ensure specimen integrity prior to processing.^[39]

Collection and Handling Methods

In histopathology, the collection and initial handling of tissue specimens are critical steps to ensure the preservation of cellular architecture and molecular integrity for accurate diagnostic analysis. These procedures vary depending on whether the specimen is obtained via biopsy or surgical resection, with the primary goal of minimizing autolysis, contamination, and structural distortion from the moment of acquisition. Proper handling begins at the point of collection in clinical or surgical settings, where immediate measures are taken to orient, document, and protect the sample. Biopsy techniques commonly employed in histopathology include fine-needle aspiration for cytology and core needle biopsies for obtaining intact tissue cylinders, often facilitated by trocars or automated biopsy guns to penetrate target lesions with precision. For core biopsies, a trocar—a hollow outer needle with a beveled edge—guides the inner cutting needle to extract a cylindrical core of tissue, typically 1-2 mm in diameter, which is essential for evaluating architectural features in organs such as the breast or prostate. To maintain spatial orientation, especially for assessing margins in potential malignancies, biopsies are marked with inks or dyes immediately after extraction; for instance, different colored inks can denote specific surfaces like anterior, posterior, or lateral edges, aiding pathologists in correlating microscopic findings with the original anatomical context. Surgical handling of resection specimens involves prompt gross examination by the surgeon or pathologist to identify key features such as tumor size, location, and involvement of margins, followed by systematic inking of the entire resection surface to demarcate surgical edges and detect microscopic tumor extension. Representative sections are then selected and submitted for processing; for example, in colorectal cancer resections, multiple cross-sections from the tumor and adjacent normal tissue are chosen to avoid sampling artifacts like uneven fixation or loss of orientation, ensuring comprehensive histopathological evaluation. This step is performed under sterile conditions to prevent microbial contamination, with tools like scalpels and forceps handled meticulously to preserve tissue integrity. Transport protocols emphasize rapid transfer to prevent degradation, often using fixative transport media such as 10% neutral buffered formalin for routine diagnostics, which stabilizes proteins and halts enzymatic activity upon immersion. Time-sensitive handling is paramount; for research applications involving molecular analyses like RNA sequencing, specimens should be fixed within 30 minutes of collection to optimize preservation, as delays beyond this threshold can lead to RNA fragmentation and reduced yield. Specimens are typically placed in leak-proof containers labeled with patient details, collection date, and site, and transported at ambient temperature for formalin-fixed samples or on ice for fresh tissues requiring minimal processing. Safety measures during collection and handling prioritize sterile techniques and biohazard precautions, particularly for tissues from patients with infectious diseases such as HIV or hepatitis. All procedures adhere to universal precautions, including the use of personal protective equipment (gloves, gowns, masks), sharps disposal, and segregation of potentially contaminated materials in biohazard bags to mitigate transmission risks to healthcare personnel. In cases of suspected prions or high-containment pathogens, additional protocols like autoclaving or incineration of waste are implemented per institutional guidelines.

Tissue Preparation

Fixation

Fixation is the initial step in tissue preparation for histopathology, aimed at stabilizing biological tissues by halting enzymatic degradation and preserving structural integrity immediately after collection. The primary purpose is to cross-link proteins through chemical reactions, preventing autolysis (self-digestion by endogenous enzymes) and putrefaction while maintaining cellular architecture and antigens for subsequent diagnostic staining and analysis.^[40]^[41] The most widely used fixative is 10% neutral buffered formalin, a 4% formaldehyde solution in phosphate buffer at pH 7, which penetrates tissues at approximately 1 mm per hour and forms methylene bridges between reactive amino groups on proteins such as lysine and cysteine, creating stable cross-links that rigidify the tissue matrix.^[40]^[41] For electron microscopy, glutaraldehyde (typically 2-2.5% in phosphate-buffered saline) serves as an alternative or primary fixative, offering superior ultrastructural preservation through extensive intra- and intermolecular protein cross-linking, though it penetrates more slowly and is often followed by secondary osmication.^[41]^[42] Optimal fixation parameters are crucial to balance preservation and avoid distortion; formalin-fixed tissues are generally immersed in fixative at a 20:1 to 25:1 volume ratio relative to tissue size, with agitation to ensure uniform penetration, at room temperature (around 21-25°C) for 24-48 hours to allow complete initial cross-linking without excessive hardening.^[40]^[41] Under-fixation (less than 6-24 hours) risks incomplete stabilization leading to autolytic artifacts like nuclear fading, while over-fixation (beyond 48 hours) can cause tissue shrinkage up to 30% and mask antigens, reducing immunoreactivity in immunohistochemical assays.^[41]^[43] A common artifact is formalin pigment, which forms as dark brown, birefringent crystalline deposits in acidic conditions (pH below 6) or in hemoglobin-rich tissues like spleen or hemorrhagic areas, resulting from the reaction of formaldehyde with heme groups.^[44] This pigment can be removed by immersing sections in saturated alcoholic picric acid for 15 minutes to overnight or in ammonia-alcohol solution for 10 minutes prior to staining, followed by thorough washing to prevent interference with microscopic interpretation.^[44]^[45]

Processing and Embedding

After fixation, tissue processing prepares specimens for embedding by removing water and replacing it with a supportive medium, ensuring structural integrity for subsequent sectioning. This multistep procedure—dehydration, clearing, and infiltration—minimizes distortion and artifacts while facilitating paraffin wax integration.^[46] Dehydration removes water from fixed tissues using a sequential gradient of ethanol solutions, typically progressing from 70% to 100% concentrations, to prevent incomplete removal that could trap moisture and cause bubble artifacts or opacity in sections. This graded approach, often involving multiple changes at each concentration (e.g., 1.5 hours in 70% ethanol, followed by two 1.5-hour immersions in 95% and three in 100%), minimizes tissue shrinkage and distortion through controlled solvent exchange.^[46]^[47]^[48] Clearing follows dehydration by displacing ethanol with an organic solvent that renders the tissue transparent and miscible with paraffin, such as xylene or less toxic substitutes like isopropyl alcohol. Agents like xylene require 2–4 changes (e.g., one hour in a 50:50 ethanol-xylene mix, followed by two one-hour xylene immersions) to effectively remove lipids and ensure uniform penetration, with agitation enhancing efficiency.^[46]^[49]^[48] Infiltration impregnates the cleared tissue with molten paraffin wax (melting point 56–60°C), typically via 2–3 changes (e.g., two one-hour immersions), often under vacuum to remove air and promote even distribution for structural support during sectioning. Embedding then molds the infiltrated tissue into paraffin blocks using embedding stations, where it is oriented and cooled (e.g., at 4°C for 15 minutes) to solidify into durable blocks suitable for microtomy.^[46]^[50]^[48] These steps are commonly automated using tissue processors that cycle through reagents over 12–16 hours, incorporating agitation and controlled temperatures to ensure uniform dehydration, clearing, and paraffin penetration across multiple specimens.^[46]^[48]

Sectioning Techniques

Paraffin Sectioning

Paraffin sectioning is the standard technique for producing thin, high-quality tissue sections from paraffin-embedded blocks, enabling detailed microscopic examination in routine histopathology diagnostics. This method involves using a rotary microtome to slice the embedded tissue into ribbons of sections, which are then mounted onto slides for subsequent processing. The process ensures preservation of morphological details while allowing serial sectioning for comprehensive analysis.^[51] Rotary microtomes are employed to generate sections typically 4-5 micrometers thick, optimal for routine histopathological evaluation as they balance detail resolution with ease of handling. The paraffin block, prepared through prior dehydration and embedding, is securely clamped into the microtome's specimen holder, with the face trimmed to expose the tissue surface. Disposable blades are inserted into the blade holder, and the clearance angle—usually set between 3-8 degrees—is adjusted to ensure clean cuts by preventing the blade from dragging on the section. Sectioning proceeds with slow, even advancement of the handwheel, producing uniform slices without excessive force.^[52]^[53]^[54] Once cut, sections are floated on a warm water bath at 40-45°C to flatten and remove wrinkles caused by compression during cutting. The bath's temperature is critical: too low prevents expansion, while too high risks tissue distortion. Sections are gently maneuvered with a brush to unfold completely before being picked up onto charged glass slides, which promote adhesion. This mounting step, often performed in a serial manner, ensures sections dry evenly for archival stability.^[55]^[56] The ribboning technique facilitates efficient serial sectioning by producing connected strips of multiple sections (typically 4-6 per ribbon), which can be transferred en masse to the water bath or adhesive-coated strips for orientation tracking. To achieve straight ribbons, the block's edges are chamfered into a trapezoid shape prior to cutting, minimizing curling; a soft brush guides the ribbon away from the blade if adhesion occurs. This method supports quality control by allowing comparison across consecutive levels.^[56]^[51] Common challenges in paraffin sectioning include variations in section thickness and chatter marks, which manifest as parallel lines from blade vibration. Thick or thin sections often result from improper blade tilt, excessive speed, or loose microtome components, and can be resolved by increasing the tilt angle slightly, maintaining moderate cutting speed, and tightening all fixtures. Chatter marks, particularly in dense tissues, are mitigated through block face trimming to reduce hardness gradients, blade replacement if dull, and application of lubrication such as anti-roll fluids on the blade edge. Proper block preparation from embedding minimizes these issues overall.^[53]^[57]^[58]

Frozen Section Processing

Frozen section processing is a rapid tissue preparation technique employed in histopathology for intraoperative consultations, enabling pathologists to provide preliminary diagnoses during surgical procedures. This method involves quick freezing of fresh tissue specimens to preserve cellular architecture for immediate sectioning and microscopic examination, contrasting with the more deliberate routine paraffin methods detailed in the Paraffin Sectioning section. The freezing process begins with the placement of unfixed tissue into a cryomold filled with Optimal Cutting Temperature (OCT) embedding medium, a water-soluble compound that supports the tissue without introducing artifacts during cryosectioning. The mold is then positioned on a pre-chilled chuck, often cooled to -20°C to -30°C within the cryostat chamber, and snap-frozen using liquid nitrogen or a similar cryogen for 10-30 seconds to minimize ice crystal formation.^[59]^[60]^[61] Once frozen, the embedded tissue block is mounted in a cryostat, a specialized low-temperature microtome maintained at -20°C to -30°C, where a cryomicrotome blade cuts sections typically 5-10 micrometers thick. These sections are transferred directly onto glass slides, bypassing dehydration and clearing steps used in paraffin processing, and are immediately available for staining, such as hematoxylin and eosin, to facilitate rapid evaluation.^[59]^[60] A key advantage of frozen section processing is its speed, allowing for diagnostic results within 20-30 minutes from specimen receipt, which is critical for intraoperative decisions like assessing surgical margins in tumor resections.^[62]^[63]^[64] However, the technique has limitations, including suboptimal tissue morphology due to ice crystal artifacts that can distort cellular details and architecture. Additionally, frozen sections exhibit a diagnostic error rate of approximately 1-2% when compared to permanent paraffin sections, primarily arising from sampling, technical, or interpretive challenges.^[65]^[66]

Staining Methods

Routine Stains

Routine stains in histopathology provide essential contrast to visualize general tissue architecture and cellular details in paraffin-embedded sections, serving as the foundation for most diagnostic evaluations. The most widely used routine stain is hematoxylin and eosin (H&E), which differentially colors nucleic acids and proteins to highlight basophilic (acid-loving) and acidophilic (base-loving) components of tissues. Hematoxylin, derived from the logwood tree, acts as a basic dye that binds to acidic structures like DNA and RNA in cell nuclei, imparting a blue-violet hue, while eosin, an acidic dye, stains cytoplasmic proteins, collagen, and extracellular matrix in shades of pink to red. This combination allows pathologists to assess morphology without targeting specific molecules, making H&E indispensable for routine diagnostics. The H&E staining protocol follows a standardized sequence to ensure reproducibility across laboratories. Sections are first dewaxed in xylene to remove embedding medium, followed by rehydration through graded alcohols to water. Tissues are then immersed in hematoxylin solution for 5-10 minutes, depending on the formulation, to achieve nuclear staining; this can be progressive (gradual buildup until desired intensity) or regressive (overstaining followed by differentiation in acid to remove excess dye). Bluing follows in an alkaline solution like ammonia water or Scott's tap water substitute for 1-5 minutes to convert the initial red hematoxylin-lake complex to the stable blue form. Eosin counterstaining occurs next for 30 seconds to 2 minutes, adjusted for tissue type, before dehydration in ascending alcohols, clearing in xylene, and mounting under a coverslip with resinous medium. These steps, typically automated in high-volume labs, yield slides ready for light microscopy within 30-60 minutes post-sectioning. H&E is the default stain for approximately 95% of surgical pathology slides, enabling visualization of tissue organization, cell types, and pathological changes in virtually all specimens, from biopsies to resections. Its universal application stems from the broad-spectrum contrast it provides, revealing architectural patterns like glandular formations or stromal fibrosis without additional reagents. Variations in protocol optimize results for specific tissues; for instance, shorter eosin exposure (10-30 seconds) prevents over-staining in fatty tissues such as adipose or liver, while longer hematoxylin times enhance nuclear detail in densely cellular samples like lymphomas. Adjustments may also include mordants like aluminum salts to intensify hematoxylin binding, ensuring consistency across diverse clinical scenarios.

Special and Histochemical Stains

Special and histochemical stains in histopathology are targeted chemical techniques designed to selectively highlight specific tissue components, such as carbohydrates, connective tissues, pathogens, or extracellular deposits, providing diagnostic insights beyond the general contrast offered by routine hematoxylin and eosin (H&E) staining. These methods rely on the differential affinity of dyes or reagents for particular molecular structures, enabling pathologists to visualize subtle features like fibrosis, infections, or protein aggregates that may be inconspicuous in standard preparations. Histochemical stains, in particular, exploit biochemical reactions to detect macromolecules, while special stains often focus on microbial elements or fibrous architectures. The Periodic Acid-Schiff (PAS) stain is a widely used histochemical method that detects polysaccharides, including glycogen and mucins, by oxidizing vicinal diols in these molecules with periodic acid to form aldehydes, which then react with Schiff's reagent to produce a magenta color. In histopathology, PAS is valuable for identifying fungal infections, basement membranes in renal biopsies, and glycogen storage diseases, where diastase digestion can differentiate glycogen (which is removed) from other PAS-positive structures like mucins in adenocarcinomas. Applications include assessing liver glycogen in metabolic disorders and highlighting goblet cell mucins in gastrointestinal pathologies. Masson's trichrome stain differentiates collagen fibers from cellular elements by employing a mixture of dyes—typically Weigert's iron hematoxylin for nuclei (black), Biebrich scarlet-acid fuchsin for cytoplasm and muscle (red), and aniline blue or light green for collagen (blue)—with the acidic environment preferentially binding the blue dye to collagen due to its high affinity for carboxylic acid groups. This stain is essential for evaluating fibrosis in liver cirrhosis, cardiac hypertrophy, and pulmonary interstitial diseases, where increased blue-staining collagen quantifies the extent of fibrotic replacement of parenchymal tissue. In renal pathology, it aids in distinguishing sclerotic glomeruli from normal structures. Special stains for pathogens, such as the Gram stain, classify bacteria based on cell wall properties: gram-positive organisms retain crystal violet-iodine complexes (appearing purple) after alcohol decolorization, while gram-negative ones lose it and counterstain pink with safranin, allowing identification of infections like staphylococcal abscesses or E. coli in tissue sections. The Ziehl-Neelsen (ZN) stain targets acid-fast bacilli, such as Mycobacterium tuberculosis, by using heated carbol fuchsin that penetrates lipid-rich cell walls, resisting decolorization with acid-alcohol and appearing red against a blue methylene counterstain, crucial for diagnosing tuberculosis in lung biopsies where bacilli may be sparse. These stains enhance detection of microbial colonies that appear nonspecific on H&E. Reticulin stains, employing silver impregnation methods like Gomori's technique, visualize type III collagen fibers in reticular frameworks by reducing silver ions onto argyrophilic fibers after sensitization with uranium nitrate or similar agents, resulting in black threads against a light background that outline hepatic sinusoids, splenic architecture, or tumor invasion patterns in lymphomas. The mechanism involves the selective deposition of metallic silver on reticulin without requiring enzymatic digestion, providing a clear view of supportive stroma in bone marrow biopsies for assessing myelofibrosis. In applications for extracellular deposits, the Congo red stain identifies amyloid by binding to beta-pleated sheet structures in fibrils, appearing salmon-pink under brightfield and exhibiting pathognomonic apple-green birefringence under polarized light due to the dye's anisotropic alignment with amyloid's ordered conformation. This is diagnostic for systemic amyloidosis in tissues like kidney or heart, distinguishing it from hyaline or collagenous deposits, and is confirmed by the potassium permanganate pretreatment test, where AA amyloid is sensitive (Congo red staining is lost after treatment), while AL amyloid is resistant (staining retained).^[67]

Microscopic Interpretation

Architectural Patterns

Architectural patterns in histopathology refer to the overall organization and spatial arrangement of tissue components observed under the microscope, which provide critical insights into the nature and behavior of pathological processes, particularly in neoplasms. These patterns are evaluated at low to medium magnification to assess how cells and extracellular elements form structures, distinguishing benign from malignant conditions and aiding in tumor classification and grading. In epithelial malignancies, such as adenocarcinomas, the preservation or disruption of glandular architecture is a key diagnostic feature, while in mesenchymal or hematopoietic tumors, stromal or inflammatory arrangements offer prognostic clues.^[68] Glandular patterns are prominent in adenocarcinomas, where neoplastic cells form organized structures mimicking normal glandular epithelium. Tubular patterns consist of simple or complex elongated ducts lined by a single or double layer of cuboidal to columnar cells, often seen in well-differentiated colorectal or prostate adenocarcinomas, reflecting partial retention of ductal differentiation. Papillary patterns feature fibrovascular cores lined by epithelial cells, projecting into cystic spaces, as commonly observed in papillary thyroid carcinoma or serous ovarian tumors, where the architecture supports invasion along fronds. Cribriform patterns, characterized by sieve-like sheets with multiple punched-out lumina, indicate intermediate differentiation and are hallmark in prostate acinar adenocarcinoma or salivary gland tumors, correlating with higher Gleason scores in prostate cancer. In contrast, undifferentiated tumors exhibit solid sheets of cells with loss of glandular formation, appearing as back-to-back nests without lumina, as in high-grade sarcomatoid carcinomas or anaplastic variants, signifying aggressive dedifferentiation and poor prognosis.^[69]^[68]^[70]^[71] Stromal interactions, particularly desmoplasia, represent a fibrotic host response to invasive cancers, where dense collagen deposition encases tumor nests. Desmoplasia arises from activation of cancer-associated fibroblasts producing extracellular matrix, forming a sclerotic barrier that facilitates tumor progression in pancreatic ductal adenocarcinoma or invasive breast carcinoma. This reaction is quantified histologically by assessing the proportion of fibrotic stroma relative to tumor cellularity, often using semi-quantitative scales such as the desmoplastic reaction classification (mature, intermediate, or immature) in colorectal cancer, where immature desmoplasia with myxoid features predicts worse survival. In grading systems, extensive desmoplasia contributes to higher scores, as in the Nottingham grading for breast cancer, where stromal invasion elicits marked fibrosis, impacting therapeutic response. Computer-assisted image analysis has been employed to measure desmoplastic extent objectively, reporting stromal fraction as a percentage, with values exceeding 50% indicating advanced invasion in prostate xenografts.^[72]^[73]^[74] Inflammatory architecture in lymphomas highlights the distribution of lymphoid cells, distinguishing organized from chaotic growth. Follicular patterns in follicular lymphoma mimic reactive germinal centers, with neoplastic B-cells forming expanded, irregularly shaped follicles that back-to-back crowd the node, often with attenuated mantles and lack of polarization, as defined in WHO classifications. Diffuse patterns, prevalent in diffuse large B-cell lymphoma, show effacement of nodal architecture by sheets of large cells without follicular remnants, leading to a star-sky appearance due to interspersed macrophages. The transition from follicular to diffuse growth in transformed lymphomas indicates progression and is assessed by the proportion of diffuse areas, with >50% diffuse component worsening prognosis. These patterns are evaluated on low-power views to confirm architecture before immunoarchitectural correlation.^[75]^[76]^[77] Quantitative assessment of architectural patterns often incorporates the mitotic index as a proliferation marker, calculated by counting mitotic figures in the most active tumor areas. The standard method involves tallying mitoses per 10 high-power fields (HPF, typically 0.196 mm² at 40x magnification) under conventional microscopy, with thresholds such as >15 mitoses/10 HPF (or >15 in 2 mm²) for mitotic score 3, contributing to high-grade (grade 3) tumors in breast carcinoma per Nottingham criteria.^[78] This index reflects proliferative activity within the tissue architecture, aiding grading in sarcomas or neuroblastomas, where elevated counts (>20/10 HPF) correlate with aggressive behavior independent of other features. Standardization of field area is crucial, as variations in microscope optics can alter counts by up to 30%, emphasizing the need for calibrated optics in reporting.^[79]^[80]^[81]

Cellular and Nuclear Features

In histopathology, the analysis of nuclear features plays a pivotal role in diagnosing malignancy, as alterations in nuclear morphology often reflect dysregulated cell growth and genetic instability. Nuclear pleomorphism, defined by significant variation in nuclear size and shape among cells within a population, is a classic indicator of neoplastic transformation across various cancer types. This irregularity arises from chromosomal aberrations and is readily observable under light microscopy in hematoxylin and eosin-stained sections.^[82] Hyperchromasia, characterized by darkly staining nuclei due to increased chromatin density, further signals rapid cell proliferation and is commonly associated with aggressive tumors. Prominent nucleoli, enlarged and intensely basophilic structures within the nucleus, denote elevated ribosomal RNA synthesis to support heightened metabolic demands in malignant cells. These features—pleomorphism, hyperchromasia, and conspicuous nucleoli—collectively aid pathologists in distinguishing malignant from benign lesions, with their presence correlating strongly with poor prognosis in many carcinomas.^[83] Cytoplasmic alterations provide complementary insights into cellular pathology, often highlighting metabolic or infectious processes. Vacuolization appears as clear, membrane-bound spaces within the cytoplasm, frequently resulting from lipid accumulation in storage disorders such as Niemann-Pick disease, a lysosomal storage condition where sphingomyelin buildup leads to foamy or vacuolated cells in affected tissues like the spleen and liver.^[84] In viral infections, eosinophilic cytoplasmic inclusions—dense, pink-staining aggregates—may form due to viral protein synthesis or cellular response, as seen in herpesvirus infections where these inclusions contribute to cytopathic effects in epithelial cells. Such changes help differentiate degenerative processes from neoplastic ones, emphasizing the cytoplasm's role in revealing underlying disease mechanisms.^[85] Identifying specific cell types is fundamental to accurate histopathological interpretation, particularly in tumors where lineage determination influences classification and therapy. Epithelial cells are typically cohesive, exhibiting cell-to-cell adhesion via junctions and often displaying polarity with basal nuclei and apical surfaces, forming glandular or sheet-like structures in tissues. In contrast, mesenchymal cells lack this cohesion, appearing as individual, elongated spindle-shaped elements embedded in extracellular matrix, which is evident in sarcomas or stromal components. Atypical mitoses, marked by aberrant spindle formation, asymmetric chromosome distribution, or tripolar divisions, represent a hallmark of malignancy, reflecting genomic chaos and distinguishing cancerous proliferation from physiologic renewal. These mitotic abnormalities are quantified in grading systems to assess tumor aggressiveness.^[86]^[87] One prominent application of these cellular and nuclear assessments is the Nottingham histological grading system for invasive breast carcinoma, which evaluates tumor behavior through three criteria: tubule formation (assessing architectural differentiation), nuclear pleomorphism (gauging size and shape variation), and mitotic count (enumerating divisions per high-power field). Each component is scored from 1 (most differentiated) to 3 (least differentiated), with the sum yielding a total grade of 1 to 3, where higher scores predict worse outcomes and guide adjuvant therapy decisions. This system, refined for reproducibility, integrates nuclear features directly into prognostic stratification.

Advanced Techniques

Immunohistochemistry

Immunohistochemistry (IHC) is a technique that leverages the specific binding of antibodies to antigens for detecting and localizing proteins within tissue sections, enabling precise identification of cellular components in histopathology. Primary antibodies, raised against target antigens, are applied to formalin-fixed paraffin-embedded (FFPE) tissue sections, where they bind selectively to epitopes on proteins of interest. This binding is amplified and visualized using secondary detection systems, such as enzyme-linked antibodies—commonly horseradish peroxidase (HRP)—that catalyze a chromogenic substrate like 3,3'-diaminobenzidine (DAB), producing a visible brown precipitate at the site of antigen localization under light microscopy. Polymer-based detection methods further enhance sensitivity by incorporating multiple enzyme molecules on a polymeric backbone, reducing background noise and improving signal intensity.^[88] Standard IHC protocols begin with deparaffinization and rehydration of FFPE sections, followed by antigen retrieval to reverse fixation-induced protein cross-linking that masks epitopes. Heat-induced antigen retrieval (HIAR), often performed using microwaves, water baths, or pressure cookers in buffers like citrate (pH 6.0) at temperatures around 95–100°C for 10–30 minutes, is the most widely adopted method, applicable to the majority of antigens. Enzymatic retrieval with proteinases such as pepsin or trypsin serves as an alternative for heat-sensitive targets, though it risks over-digestion. Post-retrieval, endogenous peroxidase is blocked with hydrogen peroxide to prevent non-specific staining, and non-specific binding is minimized using serum or protein blockers. Incubation with primary and secondary antibodies occurs at optimized dilutions and times, typically 30–60 minutes at room temperature or overnight at 4°C, followed by chromogen development and counterstaining with hematoxylin. Specificity is validated through positive controls (tissues known to express the antigen) and negative controls (omitting the primary antibody or using isotype controls) in every assay run.^[89]^[88] In diagnostic histopathology, IHC panels are selected based on differential diagnoses, employing antibodies against lineage-specific markers to classify tumors. Cytokeratins (e.g., AE1/AE3 cocktail) form a cornerstone panel for confirming epithelial differentiation in carcinomas, distinguishing them from mesenchymal or hematopoietic neoplasms by demonstrating cytoplasmic staining. For hematolymphoid malignancies, panels incorporate cluster of differentiation (CD) markers, such as CD20, a B-cell-specific antigen that shows strong membranous expression in most B-lymphocyte lymphomas, aiding in their identification and subtyping. These panels are often combined with other markers like CD3 for T-cells or CD45 for leukocytes to provide a comprehensive immunophenotype.^[90]^[91] Key applications of IHC include predictive and prognostic testing in oncology, where it guides therapeutic decisions. In breast cancer, HER2 (human epidermal growth factor receptor 2) IHC assesses membrane staining intensity and completeness, scored semiquantitatively from 0 (no staining) to 3+ (complete, intense circumferential staining in >10% of tumor cells), with scores of 3+ indicating overexpression suitable for anti-HER2 therapies like trastuzumab, while 2+ cases require reflex fluorescence in situ hybridization (FISH) confirmation. Similarly, IHC for DNA mismatch repair (MMR) proteins—MLH1, MSH2, MSH6, and PMS2—evaluates nuclear expression in colorectal and other tumors; loss of one or more proteins (e.g., isolated PMS2 loss) signals potential microsatellite instability and prompts germline testing for Lynch syndrome, a hereditary condition increasing cancer risk. These applications underscore IHC's role in personalized medicine, with standardized protocols ensuring reproducibility across laboratories.^[92]^[93]

Digital and Molecular Integration

Digital pathology has revolutionized histopathological analysis by enabling the digitization of entire glass slides into high-resolution virtual images, typically at 40x magnification, which facilitates remote consultations and integration with computational tools. Whole-slide imaging (WSI) scanners, such as those from Leica Biosystems' Aperio series and Roche's Digital Pathology Dx system, capture detailed gigapixel images that allow pathologists to review specimens without physical slides, supporting applications in telemedicine and quality assurance.^[94]^[95] These systems have demonstrated noninferiority to traditional light microscopy for primary diagnosis, with diagnostic concordance rates exceeding 95% in clinical settings.^[96] AI-assisted pattern recognition on WSI further enhances efficiency by automating feature detection, reducing interobserver variability in tumor identification.^[97] Molecular integration in histopathology combines traditional morphological assessment with genetic techniques to provide prognostic and therapeutic insights. Fluorescence in situ hybridization (FISH) is a key method for detecting gene amplifications, such as HER2 in breast cancer, where amplification is defined by a HER2/CEP17 ratio greater than 2.0, indicating eligibility for targeted therapies like trastuzumab.^[98] This ratio, assessed on interphase nuclei within histological sections, correlates strongly with clinical outcomes, with amplified cases showing aggressive tumor behavior.^[99] Next-generation sequencing (NGS) complements this by correlating genomic alterations, such as TP53 mutations, with histological grades; for instance, high-grade breast carcinomas often exhibit higher mutational burdens that align with Nottingham grading scores, aiding in personalized treatment stratification.^[100]^[101] Artificial intelligence applications in histopathology leverage machine learning to automate quantitative tasks, improving accuracy and reproducibility. Algorithms for mitotic counting in breast cancer, a critical component of tumor grading, achieve accuracies over 90% compared to manual methods, significantly reducing pathologist workload while maintaining diagnostic reliability.^[102] These deep learning models, trained on annotated whole-slide images, identify mitotic figures with precision that surpasses human interobserver agreement in high-volume settings.^[103] In tumor microenvironment analysis, AI quantifies spatial relationships between immune cells, stroma, and cancer cells, revealing immunosuppressive patterns that predict immunotherapy response; for example, convolutional neural networks can segment lymphocyte infiltration with sensitivities above 85%, informing PD-L1 expression correlations.^[104]^[105] Emerging trends in histopathology emphasize global accessibility and multimodal visualization. Telepathology networks enable real-time diagnostic consultations across regions, particularly in underserved areas, with systems achieving diagnostic accuracies of 96-97% for frozen sections and supporting collaborative cancer diagnostics in sub-Saharan Africa.^[106]^[107] Multiplex immunohistochemistry (mIHC) advances marker assessment by allowing simultaneous visualization of up to nine proteins on a single tissue section, using tyramide signal amplification to preserve spatial context and enhance understanding of heterogeneous tumor microenvironments.^[108] This technique, integrated with digital imaging, facilitates high-throughput phenotyping for precision oncology.^[109]

References

[1]
Definition of histopathology - NCI Dictionary of Cancer Terms
Listen to pronunciation. (HIS-toh-puh-THAH-loh-jee) The study of diseased cells and tissues using a microscope.
[2]
Histology: The gold standard for diagnosis? - PMC - NIH
Histopathology is an important diagnostic tool used during a workup for various problems, including cancer. It is generally recognized as the gold standard ...
[3]
Histology, Staining - StatPearls - NCBI Bookshelf
May 1, 2023 · Histology is the microscopic study of tissues and organs through sectioning, staining, and examining those sections under a microscope.
[4]
[PDF] Once Upon a Microscopic Slide: The Story of Histology
Oct 19, 2015 · The early staining techniques used by histologists and pathologists were derived from techniques developed by seventeenth century amateur.
[5]
Pathological Examinations - SEER Training Modules
Dec 28, 2023 · While histology is the study of tissue specimens, cytology is the study of cells. Cells are continually shed (exfoliated) from tissues that line ...Histologic Examination · Cytologic Examination · The Biopsy Report
[6]
Histopathology - Royal College of Pathologists
Histopathology is the diagnosis and study of diseases of the tissues, involving examining tissues and/or cells under a microscope.
[7]
[PDF] Laboratory: Anatomic Pathology User Guide - VA.gov
Sep 1, 2022 · Anatomic Pathology (AP) is divided into four sections: Surgical Pathology, Cytology. (Cytopathology), Electron Microscopy, and Autopsy Pathology ...<|control11|><|separator|>
[8]
Milestones Leeuwenhoek - Indiana Medical History Museum
In the 1670–1680s, Antonie van Leeuwenhoek, a Dutch scientist, made major contributions to the field of microscopy which revolutionized the understanding of ...<|separator|>
[9]
Some milestones in the history of histology
Feb 24, 2024 · Xavier Bichat ("the father of histology") establishes the systematic study of tissues as a discipline within anatomy by describing twenty-one ...Missing: histopathology | Show results with:histopathology
[10]
Details - Cellular pathology as based upon physiological and ...
Oct 20, 2015 · Cellular pathology as based upon physiological and pathological histology; twenty lectures delivered in the Pathological Institute of Berlin
[11]
Wilhelm His Sr. and the development of paraffin embedding - PMC
Jul 8, 2021 · The discovery of paraffin embedding is often attributed to the pathologist Edwin Klebs. Klebs was following the lead of Stricker, who embedded ...
[12]
Paul Ehrlich and the Early History of Granulocytes - ASM Journals
Paul Ehrlich's techniques, published between 1879 and 1880, for staining blood films using coal tar dyes, and his method of differential blood cell counting,
[13]
The Centennial Anniversary of the Frozen Section Technique at the ...
Dec 1, 2005 · The publication by Louis B. Wilson, MD, at the Mayo Clinic in 1905 heralded the beginning of a new era in intraoperative diagnosis.
[14]
Happenings in Histopathology – A Post-World War II Perspective
Aug 15, 2007 · There have been several important developments in the practice of histopathology since World War II; those reviewed in this lecture are grouped ...
[15]
Cancer Classification - SEER Training Modules
Cancers are classified in two ways: by the type of tissue in which the cancer originates (histological type) and by primary site, or the location in the body ...Carcinoma · Sarcoma · Leukemia
[16]
Spatial mapping reveals granuloma diversity and histopathological ...
Mar 15, 2023 · The hallmark of tuberculosis (TB) is the formation of immune cell-enriched aggregates called granulomas. While granulomas are pathologically ...
[17]
A practical histological approach to the diagnosis of autoimmune ...
Liver biopsy is crucial for the diagnosis of autoimmune hepatitis (AIH), and new reproducible histological criteria would be highly desirable.Missing: examples | Show results with:examples
[18]
The evolving role of image-guided biopsy and specimen fixation ...
Image-guided biopsy is now well established in clinical practice, due to its proven accuracy (90–95%), low complication rate (<1%) and minimally invasive ...
[19]
Underestimation of malignancy of breast core‐needle biopsy
Dec 21, 2006 · A review of the literature indicated variable underestimation rates for breast core-needle biopsy (CNB) based on generally small series.
[20]
Accuracy and underestimation of malignancy of breast core needle ...
Overall sensitivity of CNB is 94.2% (92.9-95.5%) and specificity is 88.1% (86.6-89.6%), positive and negative predictive values are 84.8% (82.9-86.7%) and 95.6% ...
[21]
WHO Classification of Tumours Online
This series is a synthesis of the published evidence and the practice of cytopathology, linked to the WHO Classification of Tumours, now in their 5th Edition.BlueBooksOnline · Features · Preview · Contact
[22]
Reporting Guidelines for Clinical Laboratory Reports in Surgical ...
Oct 1, 2008 · In this article, the Surgical Pathology Committee of the CAP puts forth its recommendations regarding the required, preferred, and optional ...
[23]
Gleason grading: past, present and future - PubMed
In 1966 Donald Gleason developed his grading and scoring system for prostatic adenocarcinoma. This classification was refined in 1974 and gained almost ...
[24]
Prostate cancer grading: a decade after the 2005 modified system
Jan 3, 2018 · This review article will cover the evolution of grading of prostate cancer from the original Gleason system in the 1960–1970s to a more patient-centric grading ...
[25]
The evolving Gleason grading system - PMC - NIH
The Gleason grading system for prostate adenocarcinoma has evolved from its original scheme established in the 1960s–1970s, to a significantly modified system.
[26]
Aβ plaques - PMC - PubMed Central - NIH
Aβ plaques are one of the two lesions in the brain that define the neuropathological diagnosis of Alzheimer's disease.<|separator|>
[27]
Alzheimer's Disease and the β-Amyloid Peptide - PMC - NIH
Alzheimer's disease (AD) pathogenesis is widely believed to be driven by the production and deposition of the β-amyloid peptide (Aβ).
[28]
Pathology Principles and Practices for Analysis of Animal Models
May 4, 2019 · Pathology analysis, including histopathology, is essential to animal model studies by providing morphologic context to in vivo, molecular, and biochemical data.Early Considerations · Pathology Considerations... · Histopathology...
[29]
Standardizing digital biobanks: integrating imaging, genomic, and ...
Feb 5, 2024 · Digital biobanks can catalyze this process, facilitating the sharing of curated and standardized imaging data, clinical, pathological and molecular data.
[30]
Genetic Testing and Tissue Banking for Personalized Oncology
Personalized oncology uses genetic testing and tissue banking to identify cancer targets, understand disease, and tailor treatments based on genomic data.
[31]
COVID-19 pulmonary pathology: a multi-institutional autopsy cohort ...
Sep 2, 2020 · Autopsy reports of the lungs in COVID-19 to date have primarily shown diffuse alveolar damage (DAD) or acute lung injury. The pulmonary autopsy ...
[32]
How Is a Biopsy Done? - American Cancer Society
Aug 1, 2023 · Needle biopsy · Endoscopic biopsy · Surgical (open) biopsy · Skin biopsies · Sentinel lymph node mapping and biopsy · Liquid biopsy.Needle Biopsy · Endoscopic Biopsy · Surgical (open) Biopsy
[33]
Types of biopsy procedures used to diagnose cancer - Mayo Clinic
Examples of surgical biopsy procedures include surgery to remove a breast lump for a possible breast cancer diagnosis and surgery to remove a lymph node for a ...Biopsy: Types Of Biopsy... · Skin Biopsy · Biopsy Analysis And Results
[34]
Surgical Pathology Reports - NCI - National Cancer Institute
Aug 8, 2022 · For some cancer types, especially breast cancer and melanoma, the surgeon may also remove nearby lymph nodes, called the sentinel lymph nodes, ...
[35]
Histopathology at autopsy: why bother? - Wiley Online Library
Jan 14, 2021 · Histopathology has a major impact on the interpretation of organ pathology and determining a cause of death at autopsy.
[36]
Role of cell block in cytopathologic evaluation of image-guided fine ...
Cell blocks allow processing of minute amounts of cellular material, enabling better tumor classification and more studies, and are not routinely prepared with ...
[37]
How Biopsy and Cytology Samples Are Processed
Apr 8, 2024 · Looking at the solid specimens in this way is called histology, which is the study of the structures of cells and tissues.
[38]
Chemical and physical basics of routine formaldehyde fixation - PMC
This article attempts to explain the chemistry of formaldehyde fixation and also to study the physical aspects involved in the fixation.
[39]
Tissue fixation and the effect of molecular fixatives on downstream ...
Fixation is the foundation step behind the study of pathology and essentially exists to prevent the autolysis and degradation of the tissue and tissue ...
[40]
Effects of Fixative and Embedding Medium on Morphology and ...
Glutaraldehyde is a stronger fixative, causing robust inter- and intra-molecular crosslinking of proteins [Hassell and Hand, 1974]. It is the fixative of ...Effects Of Fixative And... · Results · Immunostaining<|separator|>
[41]
Dermatopathology Histology Artifacts - StatPearls - NCBI Bookshelf
Jan 11, 2024 · Artifacts in tissue specimens can make interpretation difficult, especially if the pathologist is unfamiliar with the underlying etiology.
[42]
Artefacts in histopathology - PMC - NIH
Sep 4, 2014 · An artefact can be defined as an artificial structure or tissue alteration on a prepared microscopic slide as a result of an extraneous factor.Missing: parameters | Show results with:parameters
[43]
[PDF] Method-of-Histochemical-Stains-Diagnostic-Application.pdf
Procedure for Requesting Special Stains – Special stain requests can be made via electronic ordering or by using a Histopathology Special Stain Request form.
[44]
[PDF] Science of Tissue Processing - Leica Biosystems
Tissue processing is a procedure of removing water from cells and replacing it with a medium which solidifies allowing thin sections to be cut on a ...
[45]
Artifact in Histological Section - Biomedical and Pharmacology Journal
Processing artifact Incomplete dehydration leads to entrapment of water into the tissue specimen which cause inadequate staining or opacity in tissue section, ...
[46]
None
### Summary of Automated Tissue Processing Protocol (Dalhousie University)
[47]
An Introduction to Specimen Processing - Leica Biosystems
Overview of the steps in tissue processing for paraffin sections · 1. Obtaining a fresh specimen · 2. Fixation · 3. Dehydration · 4. Clearing · 5. Wax infiltration.
[48]
Tissue Processing and Embedding Services - iHisto
Automated Dehydration & Clearing Using alcohol and xylene or xylene substitutes. Paraffin Infiltration Vacuum-assisted infiltration using validated reagent ...
[49]
The Cutting and Floating Method for Paraffin-embedded Tissue for ...
Sep 5, 2018 · Paraffin sectioning is the most frequently used method for exhibiting well preserved morphology. As the specimens are dehydrated completely and ...
[50]
Preparation and Staining of Paraffin Sections - BD Biosciences
Section paraffin blocks at the desired thickness (usually 4-5 µm) on a microtome and float on a 40°C water bath containing distilled water. Transfer the ...
[51]
[PDF] MICROTOMY AND PARAFFIN SECTION PREPARATION
Common Faults. Some of the most common faults seen in paraffin sections are: A. Section too thick. » Wrong micrometer setting. » Warm breath applied to cold ...
[52]
[PDF] Microtomy and Paraffin Section Preparation
For routine use knives and disposable blades are made with a facet angle of approximately 35°, but this angle can vary with the blade type and from manufacturer ...
[53]
[PDF] Instructions for Cutting Paraffin Sections - Anatomy & Cell Biology
Set water bath to 44°C. This can be set higher if tissue sections are thicker, or lower if sections break apart or the tissue is fragile.Missing: technique | Show results with:technique
[54]
https://biomedizin.unibas.ch/fileadmin/user_upload/biomedizin/core_facilities/histology/Guides/Paraffin_methods.pdf
[55]
https://anatomy-cellbiology.ecu.edu/wp-content/pv-uploads/sites/7/Paraffin-Sectioning-Instructions.pdf
[56]
Microtomy Troubleshooting Tips - National Society for Histotechnology
May 5, 2020 · Common microtomy issues include ribbon not forming, compression, ribbon curving, sections rolling up, and thick/thin sections. Solutions ...<|control11|><|separator|>
[57]
The Art of Frozen Tissue Sectioning - Leica Biosystems
In conventional cryostats, tissue is embedded for frozen section by placing it face up on a tissue holder and covered with an embedding medium. The tissue ...
[58]
Frozen Tissue Preparation & IHC Cryosection Staining Protocol
Embed the tissue completely in OCT compound prior to cryostat sectioning. Cut frozen sections at 5-10 µm and mount on gelatin-coated histological slides.
[59]
[PDF] Tissue Freezing Methods for Cryostat sectioning
Tissue for freezing should be frozen or fixed as promptly as possible after cessation of circulation to avoid morphological distortions and damage.
[60]
Interinstitutional comparison of frozen section turnaround time. A ...
The data suggest that 90% of FS block turnaround times can be performed within 20 minutes, measured from the time that pathologists receive FS specimens to ...Missing: histopathology | Show results with:histopathology
[61]
Frozen and on Time: Rapid Margin Assessment Helps Prevent ...
Mar 27, 2018 · The bottom of the sample is frozen within seconds. That allows the pathologist to extract a razor-thin slice for review under a microscope and ...
[62]
Pathology Knowledge: How Intraoperative Rapid Frozen Section ...
Dec 6, 2021 · Results can usually be given within 30 minutes. With this technology, patients who cannot determine surgery scope of the organ can have surgery ...
[63]
Frozen section analysis of margins for head and neck tumor resections
Jan 7, 2011 · Error rates for frozen section margins are generally low, with reported frozen—permanent correlation rates as low as 96% and as high as 99%.Missing: advantages | Show results with:advantages<|control11|><|separator|>
[64]
Intra-Operative Frozen Section Consultation: Concepts, Applications ...
These limitations can be divided into three main categories namely sampling error, technical problem and interpretative error (10, 11). Sampling errors or ...
[65]
Histological patterns of head and neck tumors - PubMed Central - NIH
This pattern shows the presence of single or double layer of proliferating epithelial cells forming elongated gland-like tubular structures where the cells are ...
[66]
Ductal adenocarcinoma - Pathology Outlines
Nov 11, 2022 · Glandular, cribriform and papillary patterns. Pseudostratified columnar cells. Mitotic figures. Papillary architecture.
[67]
Morphologic patterns - Libre Pathology
Feb 26, 2025 · The big table of morphology ; Cribriform, pierced with small holes ; Solid or Sheeting, no architecture - back-to-back cells with no pattern ...
[68]
Spectrum of histologic patterns in pancreatic ductal ... - ResearchGate
The complex component was characterized by small irregular glands mixed with solid or cribriform cell sheets and individual pleomorphic cells. PDAC variants ...<|separator|>
[69]
Histopathological atlas of desmoplastic reaction characterization in ...
Apr 14, 2021 · ... fibrotic stroma in colorectal cancers. Myxoid stroma and keloid-like collagen are site-specific histopathological features generated by cancer ...Missing: quantification | Show results with:quantification
[70]
Desmoplasia measured by computer assisted image analysis - NIH
In a xenograft model, injection of human prostate cancer cells combined with stromal components into athymic nude mice resulted in a high tumour incidence as a ...
[71]
Novel Internationally Verified Method Reports Desmoplastic... - LWW
Colorectal cancer (CRC) is one of the most common cancers worldwide. To date, the tumor node metastasis staging is the basis for both prognostic stratification ...<|separator|>
[72]
Immunoarchitectural Patterns in Follicular Lymphoma
Follicular lymphoma (FL) can exhibit variant histologic patterns that can lead to confusion with other B-cell lymphomas and reactive conditions.Missing: inflammatory | Show results with:inflammatory
[73]
DLBCL, NOS - Pathology Outlines
Sep 18, 2024 · Diffuse large B cell lymphoma, NOS is a large B cell lymphoma with a diffuse growth pattern which does not meet the criteria for other WHO ...
[74]
[PDF] Follicular Lymphoma: Updates for Pathologists
Jan 15, 2022 · Follicular lymphoma (FL) is an indolent B-cell malignancy usually involving a lymph node with a morphologic appearance resembling follicular ...
[75]
Counting mitoses: SI(ze) matters! - PMC - PubMed Central - NIH
Jun 2, 2021 · In many publications, mitotic activity is given as a mitotic count, expressed as the number of mitoses per high-power field (HPF), or per 10 or ...
[76]
Mitotic Count and the Field of View Area: Time to Standardize
Dec 28, 2015 · Mitotic index is defined as the number of cells undergoing mitosis divided by the number of cells not undergoing mitoses. This can be determined ...
[77]
Assessment of proliferation in breast cancer: cell cycle or mitosis ...
Aug 28, 2021 · ... mitoses per 10 high-power field (HPF) is equivalent to score 1 and 12–22 mitoses for score 2, while score 3 is considered when >22 mitoses per ...
[78]
Nuclear morphological abnormalities in cancer - PubMed Central
Irregularities in nuclear shape and/or alterations to nuclear size are a hallmark of malignancy in a broad range of cancer types.
[79]
Diagnostic cellular abnormalities in neoplastic and non ... - NIH
In summary, nuclear irregularity, increased N/C ratio, conspicuous nucleoli, crowding and hyperchromasia proved to be the most useful indicators of malignancy.
[80]
Niemann-Pick Disease - Webpathology
Niemann-Pick disease is an autosomal recessive lipid storage disease characterized by accumulation of sphingomyelin and other lipids throughout the body.
[81]
[Histopathology of the more common viral skin infections] - PubMed
In the endothelial cells of the dermal blood vessels, cytomegalovirus produces large eosinophilic nuclear inclusions surrounded by a clear halo. Human herpes ...
[82]
Cytologic patterns | eClinpath
There are also certain types of mesenchymal tumors that mimic epithelial tumors, showing cell-to-cell adhesion, including melanoma and epithelioid variants of ...
[83]
The characteristics and clinical significance of atypical mitosis in ...
May 2, 2022 · Atypical mitosis refers to presence of unusual, dysregulated, and random assembly of nuclear materials within the dividing cells which results ...Missing: hallmarks | Show results with:hallmarks
[84]
An Introduction to the Performance of Immunohistochemistry - PMC
Jan 1, 2020 · Immunohistochemistry (IHC) is a powerful technique that exploits the specific binding between an antibody and antigen to detect and localize specific antigens ...
[85]
Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips
In this review, we attempted to provide basic principles and practical tips for practicing pathologists and residents in pathology training.
[86]
Useful Immunohistochemical Markers of Tumor Differentiation - NIH
The initial approach of most tumor diagnosis IHC applications is distinguishing epithelial from mesenchymal differentiation using vimentin and cytokeratin ...
[87]
Basic immunohistochemistry for lymphoma diagnosis - PMC - NIH
Apr 30, 2022 · Immunohistochemistry is a technique that uses antigen-antibody interactions to detect specific proteins in cells. This technique has several ...Fig. 1 · Fig. 2 · Fig. 3
[88]
HER2 Testing in Breast Cancer - 2023 Guideline Update
Best practices for distinguishing IHC 0 vs 1+ include using ASCO/CAP recommended scoring critieria, reviewing at 40x to detect faint or focal areas of ...
[89]
Screening for Lynch Syndrome by Immunohistochemistry of ...
Mar 27, 2019 · Immunohistochemical expression of mismatch repair (MMR) protein is a well-accepted method for routine screening for Lynch syndrome with relatively high ...Ihc And Scoring By Ia · Results · Discussion
[90]
The 10 Best Digital Pathology Scanners | Lumea
Nov 21, 2024 · The Leica Biosystems Aperio series of digital slide scanners offers quality, speed, and reliability, making it ideal for both diagnostic and ...
[91]
Roche Digital Pathology Dx whole slide imaging system is ...
Jun 10, 2025 · Roche Digital Pathology Dx is noninferior to manual microscopy for primary diagnosis in surgical pathology, with performance results similar to ...
[92]
Whole Slide Imaging (WSI) in Pathology: Emerging Trends and ...
Whole Slide Imaging (WSI) has emerged as a transformative technology in the fields of clinical diagnostics, medical education, and pathology research.
[93]
Contemporary Whole Slide Imaging Devices and Their Applications ...
This review focuses on integral hardware components of 43 market available and soon-to-be released digital WSI devices utilized throughout the world.
[94]
Evaluation of HER-2/neu status in breast cancer specimens using ...
Fluorescence in situ hybridization (FISH) is increasingly being recognized as the most accurate and predictive test for HER2/neu gene amplification and response ...
[95]
HER2 Amplification Associated with Breast Cancer, FISH, Tissue
A predictive marker for patients with both node-positive or node-negative primary and metastatic breast cancer.
[96]
Next‐generation sequencing in breast pathology: real impact on ...
Dec 8, 2022 · NGS offers a powerful tool that enables the pathologist to combine morphological analyses together with molecular alterations in challenging diagnostic ...
[97]
Deep learning models for histologic grading of breast cancer and ...
Oct 4, 2022 · We conducted non-inferiority analysis comparing AI-NGS to histologic grading provided by pathologists. Based on tune set results, the ...
[98]
Accuracy and efficiency of an artificial intelligence tool when ... - NIH
Jul 4, 2020 · This study demonstrates that pathology end-users were more accurate and efficient at quantifying mitotic figures in digital images of invasive breast carcinoma ...
[99]
Artificial Intelligence-Based Mitosis Scoring in Breast Cancer
Dec 26, 2023 · Deep learning supported mitoses counting on whole slide images: a pilot study for validating breast cancer grading in the clinical workflow.
[100]
Application of digital pathology‐based advanced analytics of tumour ...
AI has an increasingly powerful role in the recognition and quantitation of image features and the association of such features with clinically important ...
[101]
Artificial intelligence: illuminating the depths of the tumor ...
Aug 29, 2024 · AI has the advantage of handling large amounts of data and processing image analysis, consequently it also has a great potential in accurately assessing tumour ...
[102]
A Comprehensive Review of Advances in Digital Pathology - NIH
Oct 19, 2024 · Moreover, telepathology supports the standardization of diagnostic practices across different regions. Sharing digital slides and exchanging ...
[103]
The role of telepathology in improving cancer diagnostic ... - Frontiers
Oct 16, 2022 · In this perspective, we will describe the implementation of telepathology services in sub-Saharan Africa (SSA) that serve as cornerstones for direct patient ...
[104]
Overview of multiplex immunohistochemistry/immunofluorescence ...
Apr 17, 2020 · mIHC/IF provides high‐throughput multiplex staining and standardized quantitative analysis for highly reproducible, efficient and cost‐effective tissue studies.
[105]
Systems pathology by multiplexed immunohistochemistry and whole ...
Nov 14, 2017 · We present an mIHC platform combining fluorescent and chromogenic staining with automated whole-slide imaging and integrated whole-slide image analysis.